Endocannabinoids in liver disease
Author:
Publisher
Wiley
Subject
Hepatology
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1002/hep.24077/fullpdf
Reference107 articles.
1. The endocannabinoid system as an emerging target of pharmacotherapy;Pacher;Pharmacol Rev,2006
2. Endocannabinoid activation at hepatic CB1 receptors stimulates fatty acid synthesis and contributes to diet-induced obesity;Osei-Hyiaman;J Clin Invest,2005
3. Anandamide inhibits cholangiocyte hyperplastic proliferation via activation of thioredoxin 1/redox factor 1 and AP-1 activation;DeMorrow;Am J Physiol Gastrointest Liver Physiol,2008
4. CB1 antagonism exerts specific molecular effects on visceral and subcutaneous fat and reverses liver steatosis in diet-induced obese mice;Jourdan;Diabetes,2010
5. CB1 cannabinoid receptor antagonism: a new strategy for the treatment of liver fibrosis;Teixeira-Clerc;Nat Med,2006
Cited by 159 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Nutritional intervention is promising in alleviating liver injury during tuberculosis treatment: a review;Frontiers in Nutrition;2023-09-21
2. DAGLβ is the principal synthesizing enzyme of 2-AG and promotes aggressive phenotype of intrahepatic cholangiocarcinoma via AP-1/DAGLβ/miR4516 feedforward circuitry;American Journal of Physiology-Gastrointestinal and Liver Physiology;2023-09-01
3. The Effect of Bioactive Aliment Compounds and Micronutrients on Non-Alcoholic Fatty Liver Disease;Antioxidants;2023-04-10
4. Folic acid protects against tuberculosis-drug-induced liver injury in rats and its potential mechanism by metabolomics;The Journal of Nutritional Biochemistry;2023-02
5. Hepatic targeting of the centrally active cannabinoid 1 receptor (CB1R) blocker rimonabant via PLGA nanoparticles for treating fatty liver disease and diabetes;Journal of Controlled Release;2023-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3